Search research articles
Contact Us
Filters
Showing results (211-220 of 243) with videos related to
Page
of 25
Sort By:
Anesthesiology
|
November 1, 1992
Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release
C Stellato, R Cirillo, A de Paulis, et al.
The Journal of Allergy and Clinical Immunology
|
April 1, 1987
Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate
M D Tharp, A Kagey-Sobotka, C C Fox, et al.
Biochemical Pharmacology
|
January 15, 1990
Modulation of mediator release from human basophils and pulmonary mast cells and macrophages by auranofin
M Columbo, D Galeone, G Guidi, et al.
The American Journal of Pathology
|
October 9, 1999
Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines
P Romagnani, A De Paulis, C Beltrame, et al.
Blood
|
June 1, 1978
Role of the hypophysis in erythropoietin production during hypoxia
C Peschle, I A Rappaport, M C Magli, et al.
The Journal of Clinical Investigation
|
June 1, 1994
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor
G Ambrosio, A Oriente, C Napoli, et al.
International Archives of Allergy and Immunology
|
April 18, 2001
Expression of the chemokine receptor CCR3 on human mast cells
A de Paulis, F Annunziato, L Di Gioia, et al.
Arthritis and Rheumatism
|
July 1, 1996
Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization
A de Paulis, I MarinĂ², A Ciccarelli, et al.
Molecular Pharmacology
|
July 11, 1998
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines
M Taglialatela, A Pannaccione, P Castaldo, et al.
International Journal of Clinical & Laboratory Research
|
May 22, 1998
Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus
A Postiglione, S De Chiara, A Soricelli, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 243) with videos related to
Sort By:
Page
of 25
Anesthesiology
|
November 1, 1992
Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release
C Stellato, R Cirillo, A de Paulis, et al.
The Journal of Allergy and Clinical Immunology
|
April 1, 1987
Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate
M D Tharp, A Kagey-Sobotka, C C Fox, et al.
Biochemical Pharmacology
|
January 15, 1990
Modulation of mediator release from human basophils and pulmonary mast cells and macrophages by auranofin
M Columbo, D Galeone, G Guidi, et al.
The American Journal of Pathology
|
October 9, 1999
Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines
P Romagnani, A De Paulis, C Beltrame, et al.
Blood
|
June 1, 1978
Role of the hypophysis in erythropoietin production during hypoxia
C Peschle, I A Rappaport, M C Magli, et al.
The Journal of Clinical Investigation
|
June 1, 1994
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor
G Ambrosio, A Oriente, C Napoli, et al.
International Archives of Allergy and Immunology
|
April 18, 2001
Expression of the chemokine receptor CCR3 on human mast cells
A de Paulis, F Annunziato, L Di Gioia, et al.
Arthritis and Rheumatism
|
July 1, 1996
Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization
A de Paulis, I MarinĂ², A Ciccarelli, et al.
Molecular Pharmacology
|
July 11, 1998
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines
M Taglialatela, A Pannaccione, P Castaldo, et al.
International Journal of Clinical & Laboratory Research
|
May 22, 1998
Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus
A Postiglione, S De Chiara, A Soricelli, et al.
Page
of 25